Monthly Measure

Learn about our life-saving programs and personal insights through our Monthly Measure e-newsletter articles. Explore our full-format newsletter archive and sign up to receive the Monthly Measure straight to your inbox the first week of each month.

Treating KRAS G12C Mutated Lung Cancer: A Personal Look

2021-09-09T08:33:28-05:00September 9th, 2021|Hot Topics, Monthly Measure, Newsletter Articles, Science and Research|

Stage 4 adenocarcinoma non-small cell (aNSCLC) lung cancer treatment has been dictated in recent years by the genetic mutation, or biomarker. Patients received either chemotherapy, immunotherapy, a combination of the two, or a personalized targeted therapy depending on the [...]

Go to Top